期刊文献+

vWF与冠心病的关系 被引量:3

下载PDF
导出
摘要 目的测定冠心病患者的血管性血友病因子(von Willebrand Factor,vWF)水平,探讨vWF与冠心病的关系。方法本研究共纳入119例确立性冠心病患者和83名健康对照者。取冠心病患者(包括急性冠脉综合征亚组、稳定型心绞痛亚组)和健康对照者血液各5mL,用酶联免疫吸附法测定2组血vWF:Ag浓度,比较vWF在冠心病患者及各亚组间的关系。结果 (1)冠心病组血浆vWF:Ag水平明显高于对照组(126.73%±53.16%)VS(72.53%±48.52%),(P<0.05)。(2)稳定型心绞痛(SAP)亚组血浆vWF水平与对照组差异无统计学意义(91.37%±31.33%)VS(72.53%±48.52%),(P>0.05)。(3)急性冠脉综合征(ACS)亚组血浆vWF水平(169.24%±40.12%)较稳定型心绞痛亚组(91.37%±31.33%)、对照组(72.53%±48.52%)明显升高(P<0.05)。结论 vWF:Ag水平在冠心病患者中增高,尤其在急性冠脉综合征患者中明显增高,是冠心病的危险因素。
出处 《中外医疗》 2011年第9期30-31,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献7

  • 1Wagner D D.Cell biology of von Willebrand factor[J].Annu Rev Cell Bio1,1990:6:217- 246.
  • 2Thompson SG.Hemostatic factors and the risk of myocardial inf- arction or sudden death in patients with angina pectoris.European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group[J].N Engl J Med,1995,332:635-641.
  • 3Orstavik.Factor Ⅷ and factor IX in a twin population.Evidence for a major effect of ABO locus on factor VIII level[J].American Journal of Human Genetics,1985,37:89-101.
  • 4Wiman B.Plasma levels of tissue plasminogen activator/plasmi- nogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study[J]. Arterioscler Thromb Vasc Biol,2000,20(8):2019-2023.
  • 5Aaron R.Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease[J].Circulation,1997,96:1102- 1108.
  • 6Lytvyn OI.Interaction between inflammation and thrombosis ih acute coronary syndrome[J].Kardiol Pol,2004,61 (8): 110 - 116, discussion 114- 116.
  • 7Cambronero F.Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy[J].Thromb Res, 2010,126(1):46- 50.

同被引文献34

  • 1谢飞,王鸿利.血管性血友病因子研究进展[J].国际检验医学杂志,2006,27(7):622-624. 被引量:7
  • 2赵文杰,齐亚灵,杨利敏.辛伐他汀对冠心病患者C反应蛋白、vWF、NO、内皮素的影响[J].中国老年学杂志,2007,27(10):993-994. 被引量:2
  • 3叶福林,黄兵,杨银玉,等.高糖条件下外源性胰岛素对人脐静脉内皮细胞增殖凋亡及血管性血友病因子水平的影响[J].徐州医学院学报,2011;31(6):385-7.
  • 4McCarty O J, Conley RB, Shentu W, et al. Molecular imaging of activated von willebrand factor to detect high-risk atherosclerotic phenotype [ J ]. JACC : Cardiovascular Imaging, 2010 ; 3 ( 9 ) : 947-55.
  • 5陈灏珠.心脏病学(M].第5版.北京:人民卫生出版社,2000:227-9.
  • 6Cambronero F. Plasma levels of yon willebrand factor are increased in pa- tients with hypertrophic cardiomyopathy[ J]. Thromb Res, 2010 ;26 ( 1 ) : 46 -50.
  • 7温洪周,章翔,饶欢欢,等.CHD患者vWF和BNP的研究及临床意义[J].医药前沿,2012;2(3):393-4.
  • 8Miao Liu,Fang Wang,Yanrong Wang,Runming Jin.Atorvastatin Improves Endothelial Function and Cardiac Performance in Patients with Dilated Cardiomyopathy: The Role of Inflammation[J]. Cardiovascular Drugs and Therapy . 2009 (5)
  • 9Hanson E,Jood K,Karlsson S,et al.Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. Journal of Thrombosis and Haemostasis . 2011
  • 10Sola S,Mir MQ,Lerakis S,et al.Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. Journal of the American College of Cardiology . 2006

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部